Wai Chun Bio-Technology (HKSE:00660) Total Equity: HK$-34.7 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:00660 Wai Chun Bio-Technology Ltd HKSE:00660
23 GF Score
Price HK$0.42
! 6 Warning Signs
View Full Analysis

What is Wai Chun Bio-Technology Total Equity?

Wai Chun Bio-Technology HKSE:00660 23 Total Equity is HK$-34.7 Mil as of Dec. 2025. GuruFocus rates HKSE:00660 with a GF Score™ of 23/100. The stock has 6 warning signs investors should review.

Wai Chun Bio-Technology's total equity for the quarter that ended in Dec. 2025 was HK$-34.7 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Wai Chun Bio-Technology Total Equity Historical Data

* Premium members only.

The historical data trend for Wai Chun Bio-Technology's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Wai Chun Bio-Technology Total Equity Chart

Wai Chun Bio-Technology Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Jun22 Jun23 Jun24 Jun25
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only -23.78 6.04 10.54 -55.24 -62.65

Wai Chun Bio-Technology Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.04 -55.24 -68.80 -62.65 -34.67
HKSE:00660
23GF Score
Wai Chun Bio-Technology Ltd HKSE:00660
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Wai Chun Bio-Technology Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Wai Chun Bio-Technology's Total Equity for the fiscal year that ended in Jun. 2025 is calculated as

Total Equity=Total Assets(Q: Jun. 2025 )-Total Liabilities(Q: Jun. 2025 )
=214.655-277.308
=-62.7

Wai Chun Bio-Technology's Total Equity for the quarter that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=226.345-261.013
=-34.7

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of HK$-34.7 Mil mean?
Wai Chun Bio-Technology (HKSE:00660) has a Total Equity of HK$-34.7 Mil as of Dec. 2025. The total amount of equity as record on a company's balance sheet. View historical data for Wai Chun Bio-Technology and its competitors.
Is Wai Chun Bio-Technology's Total Equity too high?
Wai Chun Bio-Technology's current Total Equity is HK$-34.7 Mil. Overall, Wai Chun Bio-Technology has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does Wai Chun Bio-Technology's Total Equity compare to DOW?
Wai Chun Bio-Technology's Total Equity of HK$-34.7 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Chemicals company?
A good Total Equity depends on the Chemicals industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Wai Chun Bio-Technology and its competitors. Wai Chun Bio-Technology's current Total Equity is HK$-34.7 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Wai Chun Bio-Technology stock overvalued right now?
Wai Chun Bio-Technology (HKSE:00660) has a current Total Equity of HK$-34.7 Mil. The current Total Equity is HK$-34.7 Mil. Wai Chun Bio-Technology's overall GF Score™ is 23/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Wai Chun Bio-Technology (HKSE:00660), the current Total Equity is HK$-34.7 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Wai Chun Bio-Technology Business Description

Address 26 Harbour Road, Rooms 4001-02, 40th Floor, China Resources Building, Wanchai, Hong Kong, HKG
Wai Chun Bio-Technology Ltd is an investment holding company. The company has one reportable segmentbeing the manufacturing and sale of modified starch and other biochemical products. It is involved in the manufacturing and sale of modified starch and other biochemical products. Geographically, it derives a majority of its revenue from the People's Republic of China. The company also has its presence in Hong Kong.
23GF Score

Get the complete analysis for HKSE:00660

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$0.42
Price